Detalhe da pesquisa
1.
Tildrakizumab in moderate-to-severe plaque psoriasis: A multicenter, retrospective, real-life study.
Dermatol Ther
; 35(6): e15488, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384168
2.
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.
Dermatol Ther
; 35(6): e15489, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385202
3.
Differences in individual and environmental factors between cutaneous melanoma and atypical Spitz tumour in children and adolescents.
Eur J Pediatr
; 181(1): 263-269, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34275015
4.
Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.
Acta Derm Venereol
; 101(3): adv00422, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33269404
5.
Secukinumab Exhibits Sustained and Stable Response in Patients with Moderate-to-Severe Psoriasis: Results from the SUPREME Study.
Acta Derm Venereol
; 101(10): adv00576, 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903916
6.
Multiple Sclerosis Treatment and Melanoma Development.
Int J Mol Sci
; 21(8)2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32331328
7.
Melanoma and Vitiligo: In Good Company.
Int J Mol Sci
; 20(22)2019 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31731645
8.
Correction to: Differences in individual and environmental factors between cutaneous melanoma and atypical Spitz tumour in children and adolescents.
Eur J Pediatr
; 181(1): 271, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716799
9.
Effectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study.
Int J Dermatol
; 2024 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38584311
10.
Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.
J Am Acad Dermatol
; 78(3): 592-595, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28987492
11.
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience.
Drugs Context
; 122023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077769
12.
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
Clin Cosmet Investig Dermatol
; 16: 3561-3574, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38107670
13.
Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis.
Front Med (Lausanne)
; 9: 1055045, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36569153
14.
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy.
Expert Opin Biol Ther
; 21(9): 1291-1298, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34278889
15.
Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
PLoS One
; 15(4): e0222969, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352958
16.
Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development.
J Pathol Clin Res
; 6(1): 55-68, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577850
17.
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
Cell Death Dis
; 9(11): 1104, 2018 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30377293
18.
Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity.
Anticancer Res
; 27(4C): 2939-44, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17695474
19.
Mild therapeutic response of alopecia areata during treatment of psoriasis with secukinumab.
Eur J Dermatol
; 30(5): 602-603, 2020 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33185532
20.
Diagnosis and categorization of acral melanocytic lesions using teledermoscopy.
J Telemed Telecare
; 10(6): 346-50, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15603633